Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lenihan

Showing results (31-40 of 200) with videos related to

Pageof 20
Sort By:
The American Journal of the Medical Sciences|December 13, 2003
The current status of immune modulating therapy for myocarditis: a case of acute parvovirus myocarditis treated with intravenous immunoglobulinGeorge A Stouffer, Richard G Sheahan, Daniel J Lenihan, et al.
Progress in Cardiovascular Diseases|August 24, 2010
Management of cardiac disease in cancer patients. ForewordDaniel J Lenihan, Ronald J Krone
Current Cardiology Reports|June 1, 2015
Cardiotoxicity due to Chemotherapy: the Role of BiomarkersPatrick L Stevens, Daniel J Lenihan
Biochemical and Biophysical Research Communications|May 16, 1984
Regulation of platelet activating factor synthesis: modulation of 1-alkyl-2-lyso-sn-glycero-3-phosphocholine:acetyl-CoA acetyltransferase by phosphorylation and dephosphorylation in rat spleen microsomesD J Lenihan, T C Lee
The Oncologist|August 7, 2013
Overview and management of cardiac adverse events associated with tyrosine kinase inhibitorsDaniel J Lenihan, Peter R Kowey
Heart Failure Clinics|March 11, 2017
Cardio-Oncology-A Rapidly Evolving and Expanding Field of MedicineDaniel J Lenihan, Douglas B Sawyer
Cardiology Clinics|October 8, 2019
Anthracycline Cardiotoxicity: It Is Possible to Teach an Old Dog Some New TricksJose Alvarez-Cardona, Daniel J Lenihan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 30, 2008
Left ventricular ejection fraction and cardiotoxicity: is our ear really to the ground?Michael S Ewer, Daniel J Lenihan
Nature Clinical Practice. Oncology|January 24, 2008
Is trastuzumab associated with adverse cardiac effects in patients with breast cancer?Michael S Ewer, Daniel J Lenihan
The Oncologist|December 19, 2008
Multidisciplinary strategy for managing cardiovascular risks when treating patients with early breast cancerDaniel J Lenihan, Francisco J Esteva
Pageof 20

Showing results (31-40 of 200) with videos related to

Sort By:
Pageof 20
The American Journal of the Medical Sciences|December 13, 2003
The current status of immune modulating therapy for myocarditis: a case of acute parvovirus myocarditis treated with intravenous immunoglobulinGeorge A Stouffer, Richard G Sheahan, Daniel J Lenihan, et al.
Progress in Cardiovascular Diseases|August 24, 2010
Management of cardiac disease in cancer patients. ForewordDaniel J Lenihan, Ronald J Krone
Current Cardiology Reports|June 1, 2015
Cardiotoxicity due to Chemotherapy: the Role of BiomarkersPatrick L Stevens, Daniel J Lenihan
Biochemical and Biophysical Research Communications|May 16, 1984
Regulation of platelet activating factor synthesis: modulation of 1-alkyl-2-lyso-sn-glycero-3-phosphocholine:acetyl-CoA acetyltransferase by phosphorylation and dephosphorylation in rat spleen microsomesD J Lenihan, T C Lee
The Oncologist|August 7, 2013
Overview and management of cardiac adverse events associated with tyrosine kinase inhibitorsDaniel J Lenihan, Peter R Kowey
Heart Failure Clinics|March 11, 2017
Cardio-Oncology-A Rapidly Evolving and Expanding Field of MedicineDaniel J Lenihan, Douglas B Sawyer
Cardiology Clinics|October 8, 2019
Anthracycline Cardiotoxicity: It Is Possible to Teach an Old Dog Some New TricksJose Alvarez-Cardona, Daniel J Lenihan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 30, 2008
Left ventricular ejection fraction and cardiotoxicity: is our ear really to the ground?Michael S Ewer, Daniel J Lenihan
Nature Clinical Practice. Oncology|January 24, 2008
Is trastuzumab associated with adverse cardiac effects in patients with breast cancer?Michael S Ewer, Daniel J Lenihan
The Oncologist|December 19, 2008
Multidisciplinary strategy for managing cardiovascular risks when treating patients with early breast cancerDaniel J Lenihan, Francisco J Esteva
Pageof 20